Varying and "atypical" indications for atypical antipsychotics

被引：6

作者：

Barbui, C ^{[1
]}

Tansella, M

Garattini, S

机构：

[1] Univ Verona, Osped Policlin, Dept Med & Publ Hlth, Sect Psychiat, I-37134 Verona, Italy

[2] Ist Ric Farmacol Mario Negri, Milan, Italy

来源：

PSYCHOPHARMACOLOGY | 2003年 / 169卷 / 02期

关键词：

D O I：

10.1007/s00213-003-1495-x

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：205 / 206

页数：2

相关论文

共 5 条

[1] Regulatory issues in Europe
Barbui, C
Guaiana, G
Garatini, S
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (06) : 545 - 548
[2] Adjusting Europe's drug regulation to public health needs
Garattini, S
Bertele, V
[J]. LANCET, 2001, 358 (9275) : 64 - 67
[3] Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
Geddes, J
Freemantle, N
Harrison, P
Bebbington, P
[J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7273): : 1371 - 1376
[4] THE NEW ATYPICAL ANTIPSYCHOTICS - A LACK OF EXTRAPYRAMIDAL SIDE-EFFECTS AND NEW ROUTES IN SCHIZOPHRENIA RESEARCH
KERWIN, RW
[J]. BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 : 141 - 148
[5] Off-label use of antipsychotic drugs
Weiss, E
Hummer, M
Koller, D
Ulmer, H
Fleischhacker, WW
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (06) : 695 - 698